Patents by Inventor Dustin D. Ruff

Dustin D. Ruff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
    Patent number: 6528521
    Abstract: A method for treating sexual dysfunction that is caused by anti-depressant medication in a patient in need of such treatment, comprising administering a therapeutically effective amount of apomorphine, or a pharmaceutically acceptable salt thereof to said patient, is disclosed. The method may be utilized for patients taking anti-depressants such as tricyclic anti-depressants, monamine oxidase inhibitors or serotonin selective reuptake inhibitors.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: March 4, 2003
    Assignee: Tap Pharmaceutical Products, Inc.
    Inventors: Dustin D. Ruff, Renee J. Perdok
  • Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
    Publication number: 20020115683
    Abstract: A method for treating sexual dysfunction in a patient taking anti-depressant medication in need of such treatment comprising administering a therapeutically effective amount of apomorphine or a pharmaceutically acceptable salt thereof to said patient is disclosed. The method may be utilized for patients taking anti-depressants such as tricyclic anti-depressants, monamine oxidase inhibitors or serotonin selective reuptake inhibitors.
    Type: Application
    Filed: November 14, 2001
    Publication date: August 22, 2002
    Inventors: Dustin D. Ruff, Renee J. Perdok
  • Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
    Publication number: 20020086876
    Abstract: A method for treating sexual dysfunction in a patient taking anti-depressant medication in need of such treatment comprising administering a therapeutically effective amount of apomorphine or a pharmaceutically acceptable salt thereof to said patient is disclosed. The method may be utilized for patients taking anti-depressants such as tricyclic anti-depressants, monamine oxidase inhibitors or serotonin selective reuptake inhibitors.
    Type: Application
    Filed: October 10, 2001
    Publication date: July 4, 2002
    Inventors: Dustin D. Ruff, Renee J. Perdok
  • Use of apomorphine for the treatment of organic erectile dysfunction in males
    Patent number: 6291471
    Abstract: A method of treating organic erectile dysfunction, particularly vasculogenic erectile dysfunction comprises administering to a male in need of such treatment a therapeutically effective amount of apomorphine or a pharmaceutically acceptable salt or pro-drug thereof.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: September 18, 2001
    Assignee: ABB Holdings, Inc.
    Inventors: Karen Kling, Renee J. Perdok, Dustin D. Ruff